VSTM•benzinga•
Guggenheim Maintains Buy on Verastem, Raises Price Target to $14
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 24, 2025 by benzinga